Human papillomavirus vaccine acceptance among young men in Bangalore, India

Hrishikesh Kumar Belani; Poorani Sekar; Rajarshi Guhaniyogi; Anil Abraham; Paul R. Bohjanen; Kim Bohjanen

doi:10.1111/ijd.12401

Back

Human papillomavirus vaccine acceptance among young men in Bangalore, India

Journal article

Open access

Peer reviewed

Human papillomavirus vaccine acceptance among young men in Bangalore, India

Hrishikesh Kumar Belani, Poorani Sekar, Rajarshi Guhaniyogi, Anil Abraham, Paul R. Bohjanen and Kim Bohjanen

International journal of dermatology, Vol.53(11), pp.E486-E491

11/01/2014

DOI: 10.1111/ijd.12401

PMCID: PMC4205173

PMID: 24961359

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/4205173View

Open Access

Abstract

BackgroundHuman papillomavirus (HPV) is the most common sexually transmitted infection in the world. It can lead to anogenital, cervical, and head and neck cancer, with higher risk of malignant disease in patients with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. In India, 73,000 of the 130,000 women diagnosed with cervical cancer die annually. Gardasil((R)), a vaccine available against HPV types 6, 11, 16, and 18, is approved for use in women in India but not men. A backlash to post-licensure trials has created a negative public opinion of the vaccine for women. Vaccinating boys and men is an alternate approach to prevent cervical cancer in women. This study gauges facilitators and barriers to vaccination acceptance among men in Bangalore, India. Materials and methodsYoung men presenting to a dermatology clinic or an ART center in Bangalore, India, answered a seven-point survey assessing acceptance of the HPV vaccine, perceived barriers to vaccination, and acceptance of vaccination for their children. Ninety-three general dermatology patients and 85 patients with HIV/AIDS participated. ResultsThere was a high degree of vaccine acceptance for both groups, 83 and 98%, respectively. Vaccine side effects and cost were cited as key barriers to vaccination, and doctor recommendation and government approval were the main facilitators. ConclusionThere is potential for high acceptability of the HPV vaccine among men in India. These results can facilitate further study of vaccine acceptance among males and physician opinion and knowledge about HPV vaccine use. Vaccination of males is a hopeful strategy to protect men and women from HPV-related malignancies.

Dermatology

Life Sciences & Biomedicine

Science & Technology

Details

Title: Subtitle: Human papillomavirus vaccine acceptance among young men in Bangalore, India
Creators: Hrishikesh Kumar Belani - St. John's National Academy of Health Sciences
Poorani Sekar - St. John's National Academy of Health Sciences
Rajarshi Guhaniyogi - St. John's National Academy of Health Sciences
Anil Abraham - St. John's National Academy of Health Sciences
Paul R. Bohjanen - St. John's National Academy of Health Sciences
Kim Bohjanen - St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India
Resource Type: Journal article
Publication Details: International journal of dermatology, Vol.53(11), pp.E486-E491
DOI: 10.1111/ijd.12401
PMID: 24961359
PMCID: PMC4205173
NLM abbreviation: Int J Dermatol
ISSN: 0011-9059
eISSN: 1365-4632
Publisher: Wiley
Number of pages: 6
Grant note: K24AI096925 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID) K24 AI096925 / NIAID NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Language: English
Date published: 11/01/2014
Academic Unit: Infectious Diseases; Internal Medicine
Record Identifier: 9984359910902771

Metrics

9 Record Views

12 Times Cited - Web of Science